Figshare
open access
CC BY 4.0
Table 3_Tumor lysis syndrome in breast cancer: a systematic review of the literature.docx
Background Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency well-characterized in hematologic malignancies but considered rare in solid tumors. In breast cancer, TLS has been documented only in sporadic case reports, and the evolving treatment landscape—including CDK4/6 inhibit
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Table 1_Tumor lysis syndrome in breast cancer: a systematic review of the literature.docx#1328739
- Table 2_Tumor lysis syndrome in breast cancer: a systematic review of the literature.docx#1328740
- A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting#1009753
- Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212#827347
- A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer#894271
Record · ID 1328738
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive